Thermo Fisher Scientific

Name: Thermo Fisher Scientific
Address: Fraunhoferstr. 11, Martinsried, 82152, DE
Telephone: 49 2304 932 5

Startseite
Deutschland
Martinsried
Thermo Fisher Scientific

Kontaktinformationen, Karte und Wegbeschreibungen, Kontaktformulare, Öffnungszeiten, Dienstleistungen, Bewertungen, Fotos, Videos und Ankündigungen von Thermo Fisher Scientific, Biotechnologieunternehmen, Fraunhoferstr. 11, Martinsried.

28/07/2026

Myths busted! Thermo Fisher Scientific Junior Innovators Challenge competitors take on some common misconceptions about getting involved in STEM.

As they show us, big ideas can start small. All you need is a question, a spark, and the courage to try.

Watch the video and learn more about the competition here: https://www.societyforscience.org/jic/

27/07/2026

"The challenges that microscopists aim to solve — for example, designing better battery materials, understanding how diseases progress at the molecular level, developing cleaner industrial processes and building the next generation of semiconductors — require more than incremental thinking," writes Thermo Fisher's Lee Pullan in Microscopy Today.

That perspective resonates at the annual Women in Microscopy breakfast, where people across the microscopy community come together to share ideas, build connections and support one another’s growth.

As Lee notes, progress in electron microscopy is shaped by a wide array of perspectives and by the community that helps those perspectives thrive. We are proud to support this gathering and to celebrate everyone helping shape what comes next in microscopy.

Read more from Lee: https://academic.oup.com/mt/article/34/4/22/8729254?utm_source=authortollfreelink&utm_campaign=mt&utm_medium=email

22/07/2026

For patients with suspected acute leukemia, getting answers faster can make a difference.

Rapid next-generation sequencing (NGS) analyzes the cancer's DNA to identify genetic changes that can help inform personalized treatment decisions.

Dr. Valentina Nardi of Mass General Brigham says clinicians can test patients with suspected acute leukemia while they are still in the emergency department. By the time they reach the inpatient floor, they may already have genetic results.

“To be able to start treatment sooner, to understand what the disease is sooner also means that patients can leave the hospital sooner,” adds Dr. Amir Fathi of Massachusetts General Hospital.

Learn how rapid next-generation sequencing technologies are helping clinicians access genetic insights faster for patients: https://www.thermofisher.com/us/en/home/clinical/preclinical-companion-diagnostic-development/oncomine-oncology/education/rapid-ngs-cancer-diagnostics-timely-genomic-insights.html

21/07/2026

Making the world healthier, cleaner and safer extends beyond the work we do with our customers. It also means investing in our communities, supporting our colleagues and taking meaningful action for a healthier planet.

Our 2025 Corporate Social Responsibility highlights show how more than 120,000 colleagues around the world are helping create that impact—from ensuring product quality and strengthening workplace safety to supporting future innovators and advancing our path toward net-zero emissions.

Explore the latest data and stories behind how our colleagues turn commitments into action every day: thermofisher.com/csr

20/07/2026

We recently welcomed the Cellerator team to our Oslo site for two days of scientific exchange, hands-on learning and discussions focused on the future of cell therapy.

By bringing together Cellerator's mission to accelerate the development and manufacturing of cell therapies for clinical trials with Thermo Fisher's expertise in technologies and solutions that support this journey, the visit created opportunities to explore both the challenges and opportunities involved in advancing new therapies.

Drawing on expertise from both organizations, discussions focused on workforce development, process optimization and integrated approaches to cell therapy development and manufacturing that can help support the translation of promising cell therapies from research to clinical application.

Both Cellerator and Thermo Fisher recognize the important role collaboration plays in advancing innovation and expanding access to emerging therapies. Throughout the visit, scientists, engineers and technical experts shared knowledge, discussed industry challenges and explored ways to help strengthen the broader cell therapy ecosystem.

Thank you to the Cellerator team for the opportunity to collaborate and support their important work, and to our colleagues in Oslo and across Thermo Fisher who helped make this visit possible.

We look forward to continuing our collaboration and helping bridge the gap from technology to treatment in the rapidly evolving field of cell therapy.

16/07/2026

Your DNA tells you what could happen. Your proteins show what's happening right now.

For years, precision medicine has been driven by genomics. In a new perspective, Thermo Fisher's Iain Mylchreest explains why he believes proteomics is reaching a turning point.

Proteins provide a real-time view of what's happening inside the body, offering insights that DNA alone can't provide. Until recently, studying them at the scale needed for precision medicine wasn't possible. Today, advances in mass spectrometry and other technologies are enabling researchers to analyze proteins faster, more deeply and across larger populations than ever before.

For Iain, this marks a shift. By combining proteomics with genomics, researchers can build a more complete picture of human biology, bringing precision medicine closer to helping more patients receive care tailored to their unique biology.

Read Iain's perspective: https://www.labmate-online.com/article/laboratory-products/3/thermo-fisher-scientific/a-sharper-lens-how-proteomics-is-making-precision-medicine-a-reality/3819

15/07/2026

We were honored to welcome Her Excellency Mina Noor, Ambassador of the Kingdom of the Netherlands to the Czech Republic, and representatives of the Dutch Embassy to our site in Brno. The visit highlighted the strong collaboration between our Brno and Eindhoven teams and the important role international partnerships play in advancing science and technology.

During the visit, we showcased how our Brno colleagues design and manufacture advanced electron microscopy technologies that help researchers, manufacturers and innovators around the world tackle complex challenges — from developing new materials and semiconductors to advancing life sciences and improving quality in manufacturing.

A memorable highlight was a live electron microscopy demonstration, featuring a personalized engraving on a Czech coin that could only be seen under an electron microscope, illustrating the remarkable precision of the technology.

We are proud of the expertise and dedication of our colleagues in Brno. Every instrument they design and build helps our customers advance scientific discovery, develop new technologies and solve challenges that make a difference in people's lives.

14/07/2026

Every day, our customers take on some of the world's biggest challenges. From advancing medical research to protecting our environment and more, they're turning scientific questions into real-world progress.

As their trusted partner, we're helping accelerate discoveries and bring innovations to life, providing the technologies, expertise and support that help move science forward.

Because when science and innovation advance, the impact reaches far beyond the lab. Together, we're helping create healthier lives, a cleaner environment and a safer world.

09/07/2026

New Approach Methodologies, or NAMs, are human-relevant, non-animal approaches that are helping reshape how science evaluates safety and efficacy earlier in drug development.

3 things to know:

1. They can help change how drug development starts. New Approach Methodologies use tools like cell-based models, in chemico assays and computational modeling to help evaluate safety and efficacy earlier in development.

2. Momentum is growing. In 2025, the FDA and other regulatory bodies signaled stronger support for NAMs, including guidance that encourages developers to include NAM-derived data and a broader push to phase out animal testing for some programs.

3. They depend on rigorous science. Organoids, tumoroids and advanced analytical tools can help generate data that is more human-relevant, and Thermo Fisher is helping customers build and validate the workflows behind that shift.

NAMs are not a short-term trend. They are part of a multi-year transformation toward more human-relevant research, with the potential to improve safety, reduce cost and help bring new therapies forward sooner.

Learn more about the potential of NAMs in this Q&A with Thermo Fisher’s John Bishop: https://corporate.thermofisher.com/us/en/index/newsroom/Our-stories/New-Approach-Methodologies-FAQ.html

07/07/2026

After analyzing tiny, uncontaminated samples recovered from the ancient asteroid Ryugu, a global team of scientists discovered amino acids, uracil and niacin — molecules critical to life on Earth.

Advanced analytical technologies from Thermo Fisher Scientific helped make that discovery possible, turning a tiny sample into insight that could help scientists better understand when and where life began.

Learn more about how discoveries like this are helping scientists uncover clues about life’s origins: https://corporate.thermofisher.com/us/en/index/newsroom/Our-stories/scientists-discover-building-blocks-of-life-in-asteroid-ryugu.html

Adresse

Fraunhoferstr. 11
Martinsried
82152

Telefon

49 2304 932 5

Webseite

https://www.thermofisher.com/

Benachrichtigungen

Lassen Sie sich von uns eine E-Mail senden und seien Sie der erste der Neuigkeiten und Aktionen von Thermo Fisher Scientific erfährt. Ihre E-Mail-Adresse wird nicht für andere Zwecke verwendet und Sie können sich jederzeit abmelden.